Nirav Dhanesha and LSU Health Shreveport Team Discover Neutrophil Integrin α9 as a Key Target in Subarachnoid Hemorrhage Recovery
Nirav Dhanesha, Assistant Professor at the Louisiana State University, shared an important post on LinkedIn:
“Excited to share our latest research on subarachnoid hemorrhage SAH! Our study in Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) reveals a novel role for neutrophil integrin α9 ITGA9 in sensorimotor and cognitive recovery after SAH.
We found that targeting ITGA9, which is expressed on neutrophils, significantly reduces inflammation and neuronal apoptosis. This leads to improved long-term outcomes after SAH.
Huge congratulations to the first author, Harpreet Kaur, Ph.D. for her outstanding work and dedication to this project! Her dedication was instrumental in the success of this study.
Special thanks to all the co-authors Arif Yurdagul Oren Rom, PhD, RD Wayne Orr Mohammad Alfrad Nobel Bhuiyan, PhD Rajesh Mohandas Ajit Vikram Kevin Murnane Xiao-Hong Lu for their invaluable support and collaborative spirit. This was a true team effort! LSU Health Shreveport”
Read the article here:
Article: Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage
Authors: Harpreet Kaur, Nilesh Pandey, Lakshmi Chandaluri, Nirvana Shaaban, Dhananjay Kumar, Rajan Pandit, Alexa Martinez, Sumit Kumar Anand, Sandeep Das, Sumati Rohilla, Fabio Arias, Erika Reece, Ravinder Reddy Gaddam, Kevin S. Murnane, Ajit Vikram, Rajesh Mohandas, Xiaolu Zhang, Mohammad Alfrad Nobel Bhuiyan, Xiao-Hong Lu, A. Wayne Orr, Oren Rom, Arif Yurdagul Jr, Nirav Dhanesha

Follow the latest insights in hematology with Hemostasis Today.
-
Oct 28, 2026, 23:39Paul Tortland: What a New PRP Study Really Tells Us About Knee Osteoarthritis
-
Oct 28, 2026, 23:34Jawad Derbas: Comparing Mechanical and Pharmacomechanical VTE Prophylaxis in Spine Surgery
-
Oct 28, 2026, 23:31Giulio Maria Pasinetti: Aspirin Use Linked to Lower Dementia Risk in Older Adults With Specific Genetic Characteristics
-
Oct 28, 2026, 23:27Ralf Ludwig: Targeting Neutrophil-Driven Autoimmunity Through CDK Inhibition
-
Oct 28, 2026, 23:26Houda Moustaide: Great Discussions During Our Training Day on Thrombocytopenia in Pregnancy
-
Oct 28, 2026, 23:22Keith Berelowitz: Building Better Medicines by Listening to Patients With Bleeding Disorders
-
Oct 28, 2026, 23:19Nickie Enos: Blood Clots in Arteries and Veins Differ in Symptoms and Treatment
-
Oct 28, 2026, 23:17David Rosenblum: Can Concentrated PRP Actually Cause Scar Tissue?
-
Oct 28, 2026, 23:15Shueh Hao Lim: Advancing Multidisciplinary Care for Venous Thromboembolism in Malaysia